Atlas Trials

Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg

Clinical trial NCT04071821 · UNKNOWN

Trial details

NCT number
NCT04071821
Sponsor
Seattle Gummy Company
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Allergy
Start date
2025-05-01
Primary completion
2025-07-15
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.